Literature DB >> 31493132

Role of purines in regulation of metabolic reprogramming.

Zhenwei Tang1,2,3,4, Wenrui Ye4, Haotian Chen4, Xinwei Kuang1,2,3, Jia Guo1,2,3, Minmin Xiang1,2,3, Cong Peng1,2,3, Xiang Chen5,6,7, Hong Liu8,9,10,11.   

Abstract

Purines, among most influential molecules, are reported to have essential biological function by regulating various cell types. A large number of studies have led to the discovery of many biological functions of the purine nucleotides such as ATP, ADP, and adenosine, as signaling molecules that engage G protein-coupled or ligand-gated ion channel receptors. The role of purines in the regulation of cellular functions at the gene or protein level has been well documented. With the advances in multiomics, including those from metabolomic and bioinformatic analyses, metabolic reprogramming was identified as a key mechanism involved in the regulation of cellular function under physiological or pathological conditions. Recent studies suggest that purines or purine-derived products contribute to important regulatory functions in many fundamental biological and pathological processes related to metabolic reprogramming. Therefore, this review summarizes the role and potential mechanism of purines in the regulation of metabolic reprogramming. In particular, the molecular mechanisms of extracellular purine- and intracellular purine-mediated metabolic regulation in various cells during disease development are discussed. In summary, our review provides an extensive resource for studying the regulatory role of purines in metabolic reprogramming and sheds light on the utilization of the corresponding peptides or proteins for disease diagnosis and therapy.

Entities:  

Keywords:  Metabolic reprogramming; Purines; Signal transduction; Target therapy

Mesh:

Substances:

Year:  2019        PMID: 31493132      PMCID: PMC6923298          DOI: 10.1007/s11302-019-09676-z

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  194 in total

Review 1.  HIF transcription factors, inflammation, and immunity.

Authors:  Asis Palazon; Ananda W Goldrath; Victor Nizet; Randall S Johnson
Journal:  Immunity       Date:  2014-10-16       Impact factor: 31.745

Review 2.  Targeting lactate metabolism for cancer therapeutics.

Authors:  Joanne R Doherty; John L Cleveland
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

3.  Nanobodies that block gating of the P2X7 ion channel ameliorate inflammation.

Authors:  Welbeck Danquah; Catherine Meyer-Schwesinger; Björn Rissiek; Carolina Pinto; Arnau Serracant-Prat; Miriam Amadi; Domenica Iacenda; Jan-Hendrik Knop; Anna Hammel; Philine Bergmann; Nicole Schwarz; Joana Assunção; Wendy Rotthier; Friedrich Haag; Eva Tolosa; Peter Bannas; Eric Boué-Grabot; Tim Magnus; Toon Laeremans; Catelijne Stortelers; Friedrich Koch-Nolte
Journal:  Sci Transl Med       Date:  2016-11-23       Impact factor: 17.956

4.  Metabolic Reprogramming Supports IFN-γ Production by CD56bright NK Cells.

Authors:  Sinéad E Keating; Vanessa Zaiatz-Bittencourt; Roisín M Loftus; Ciara Keane; Kiva Brennan; David K Finlay; Clair M Gardiner
Journal:  J Immunol       Date:  2016-02-12       Impact factor: 5.422

5.  Acquired resistance to metformin in breast cancer cells triggers transcriptome reprogramming toward a degradome-related metastatic stem-like profile.

Authors:  Cristina Oliveras-Ferraros; Alejandro Vazquez-Martin; Elisabet Cuyàs; Bruna Corominas-Faja; Esther Rodríguez-Gallego; Salvador Fernández-Arroyo; Begoña Martin-Castillo; Jorge Joven; Javier A Menendez
Journal:  Cell Cycle       Date:  2014-02-07       Impact factor: 4.534

6.  Long-term heart transplant survival by targeting the ionotropic purinergic receptor P2X7.

Authors:  Andrea Vergani; Sara Tezza; Francesca D'Addio; Carmen Fotino; Kaifeng Liu; Monika Niewczas; Roberto Bassi; R Damaris Molano; Sonja Kleffel; Alessandra Petrelli; Antonio Soleti; Enrico Ammirati; Maria Frigerio; Gary Visner; Fabio Grassi; Maria E Ferrero; Domenico Corradi; Reza Abdi; Camillo Ricordi; Mohamed H Sayegh; Antonello Pileggi; Paolo Fiorina
Journal:  Circulation       Date:  2012-12-18       Impact factor: 29.690

7.  Protective role of reactive astrocytes in brain ischemia.

Authors:  Lizhen Li; Andrea Lundkvist; Daniel Andersson; Ulrika Wilhelmsson; Nobuo Nagai; Andrea C Pardo; Christina Nodin; Anders Ståhlberg; Karina Aprico; Kerstin Larsson; Takeshi Yabe; Lieve Moons; Andrew Fotheringham; Ioan Davies; Peter Carmeliet; Joan P Schwartz; Marcela Pekna; Mikael Kubista; Fredrik Blomstrand; Nicholas Maragakis; Michael Nilsson; Milos Pekny
Journal:  J Cereb Blood Flow Metab       Date:  2007-08-29       Impact factor: 6.200

8.  THE METABOLISM OF TUMORS IN THE BODY.

Authors:  O Warburg; F Wind; E Negelein
Journal:  J Gen Physiol       Date:  1927-03-07       Impact factor: 4.086

9.  Metformin suppresses hypoxia-induced stabilization of HIF-1α through reprogramming of oxygen metabolism in hepatocellular carcinoma.

Authors:  Xinke Zhou; Jitao Chen; Gao Yi; Min Deng; Hao Liu; Min Liang; Boyun Shi; Xin Fu; Yuqin Chen; Liangcai Chen; Zhimin He; Jian Wang; Jifang Liu
Journal:  Oncotarget       Date:  2016-01-05

10.  Uncoupling protein 2 downregulation by hypoxia through repression of peroxisome proliferator-activated receptor γ promotes chemoresistance of non-small cell lung cancer.

Authors:  Mingxing Wang; Guoyin Li; Zhiwei Yang; Lei Wang; Lei Zhang; Ting Wang; Yimeng Zhang; Shengli Zhang; Yong Han; Lintao Jia
Journal:  Oncotarget       Date:  2017-01-31
View more
  8 in total

1.  4-Pyridone-3-carboxamide-1-β-D-ribonucleoside (4PYR)-A Novel Oncometabolite Modulating Cancer-Endothelial Interactions in Breast Cancer Metastasis.

Authors:  Patrycja Koszalka; Barbara Kutryb-Zajac; Paulina Mierzejewska; Marta Tomczyk; Joanna Wietrzyk; Pawel K Serafin; Ryszard T Smolenski; Ewa M Slominska
Journal:  Int J Mol Sci       Date:  2022-05-21       Impact factor: 6.208

Review 2.  In Search of a Role for Extracellular Purine Enzymes in Bone Function.

Authors:  Mariachiara Zuccarini; Patricia Giuliani; Francesco Caciagli; Renata Ciccarelli; Patrizia Di Iorio
Journal:  Biomolecules       Date:  2021-04-30

Review 3.  P2X7 Receptor in the Management of Energy Homeostasis: Implications for Obesity, Dyslipidemia, and Insulin Resistance.

Authors:  Roberto Coccurello; Cinzia Volonté
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-12       Impact factor: 5.555

Review 4.  Adenine-Based Purines and Related Metabolizing Enzymes: Evidence for Their Impact on Tumor Extracellular Vesicle Activities.

Authors:  Patrizia Di Iorio; Renata Ciccarelli
Journal:  Cells       Date:  2021-01-19       Impact factor: 6.600

Review 5.  Multiomics Integration in Skin Diseases with Alterations in Notch Signaling Pathway: PlatOMICs Phase 1 Deployment.

Authors:  Lucas André Cavalcanti Brandão; Paola Maura Tricarico; Rossella Gratton; Almerinda Agrelli; Luisa Zupin; Haissam Abou-Saleh; Ronald Moura; Sergio Crovella
Journal:  Int J Mol Sci       Date:  2021-02-03       Impact factor: 5.923

Review 6.  In Vivo Positron Emission Tomography Imaging of Adenosine A2A Receptors.

Authors:  Meng-Juan Sun; Fang Liu; Ya-Fei Zhao; Xiao-Ai Wu
Journal:  Front Pharmacol       Date:  2020-11-26       Impact factor: 5.810

7.  ADP Induces Blood Glucose Through Direct and Indirect Mechanisms in Promotion of Hepatic Gluconeogenesis by Elevation of NADH.

Authors:  Xinyu Cao; Xiaotong Ye; Shuang Zhang; Li Wang; Yanhong Xu; Shiqiao Peng; Yang Zhou; Yue Peng; Junhua Li; Xiaoying Zhang; Xiao Han; Wen-Ying Huang; Weiping Jia; Jianping Ye
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-27       Impact factor: 5.555

Review 8.  Purinergic receptors are a key bottleneck in tumor metabolic reprogramming: The prime suspect in cancer therapeutic resistance.

Authors:  Hamid Aria; Marzieh Rezaei; Shima Nazem; Abdolreza Daraei; Ghasem Nikfar; Behnam Mansoori; Maryam Bahmanyar; Alireza Tavassoli; Mohammad Kazem Vakil; Yaser Mansoori
Journal:  Front Immunol       Date:  2022-08-22       Impact factor: 8.786

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.